ICAR GUIDELINES Bundle (free trial)

Rhinology and Allergy Rhinosinusitis

ICAR IFAR GUIDELINES brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512430

Contents of this Issue

Navigation

Page 14 of 27

15 INCS - Intranasal Corticosteroid, IV - Intravenous, MAP - Mean Arterial Pressure, MT - Middle Turbinate, wNP - with Nasal Polyps. Note - "Insufficient Evidence" refers to Grade C, D, or lack of evidence exclusive of AMT NOT RECOMMENDED INSUFFICIENT EVIDENCE Confirmation by CT and/or Endoscopy: • Absence of Nasal Polyps: CRSsNP • Presence of Nasal Polyps: CRSwNP AND Mucosal Stripping Extended Frontal Surgery Concurrent Septoplasty MT Resection Inert Stents Topical Decongestants Mitomycin C ALL CRS Topical/IV Antibiotics Oral Antifungals Topical Antifungals Colloidal Silver CRSwNP Non-Macrolide Antibiotics • <3 weeks ALL CRS Probiotics Decongestants Mucolytics Herbal Medication Surfactants Manuka Honey Capsaicin Non-Macrolide Antibiotics CRSsNP CS Atomizers CS Exhalation Delivery CS Irrigation Tubes Biologics Anti-Leukotrienes Furosemide

Articles in this issue

view archives of ICAR GUIDELINES Bundle (free trial) - Rhinology and Allergy Rhinosinusitis